Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists

Chemistry and Biology

Volumn 6, Issue 8, 1999, Pages 519-529

  Géhin, Martine ^a   Vivat, Valérie ^a   Wurtz, Jean Marie ^a   Losson, Régine ^a   Chambon, Pierre ^a   Moras, Dino ^a   Gronemeyer, Hinrich ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Retinoic acid receptors; Retinoids; Selectivity

Indexed keywords

ANIMALIA; ESCHERICHIA COLI; SACCHAROMYCES CEREVISIAE;

EID: 0033179675     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(99)80084-2     Document Type: Article

References (41)

1. Gronemeyer, H. & Laudet, V. (1995). Nuclear receptors. Protein Profile 2, 1173-1308.
2. Chambon, P. (1996). A decade of molecular biology of retinoic acid receptors. FASEB J. 10, 940-954.
3. Mangelsdorf, D.J., et al., & Evans, R.M. (1995). The nuclear receptor superfamily: The second decade. Cell 83, 835-839.
4. Mangelsdorf, D.J. & Evans, R.M. (1995). The RXR heterodimers and orphan receptors. Cell 83, 841-850.
5. Kastner, P., Mark, M. & Chambon, P. (1995). Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life? Cell 83, 859-869.
6. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H. & Moras, D. (1995). Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375, 377-382.
7. Renaud, J.P., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H. & Moras, D. (1995). Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378, 681-689.
8. Wagner, R.L., Apriletti, J.W., McGrath, M.E., West, B.L., Baxter, J.D. & Fletterick, R.J. (1995). A structural role for hormone in the thyroid hormone receptor. Nature 378, 690-697.
9. Wurtz, J.M., et al., & Gronemeyer, H. (1996). A canonical structure for the ligand-binding domain of nuclear receptors. Nat. Struct. Biol. 3, 87-94.
10. Darimont, B.D. et al., & Yamamoto, K.R. (1998). Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12, 3343-3356.
11. Nolte, R.T. et al., & Milburn, M.V. (1998). Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395, 137-143.
12. Shiau, A.K. et al., & Greene, G.L. (1998). The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95, 927-937.
13. Moras, D., & Gronemeyer, H. (1998). The nuclear receptor ligand-binding domain: Structure and function. Curr. Opin. Cell. Biol. 10, 384-391.
14. Torchia, J., Glass, C., & Rosenfeld, M.G. (1998) Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell. Biol. 10, 373-383.
15. Brzozowski, A.M., et al., & Carlquist, M. (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753-758.
16. Dey, A., S. Minucci & K. Ozato. (1994). Ligand-dependent occupancy of the retinoic acid receptor beta 2 promoter in vivo. Mol. Cell Biol. 14, 8191-8201.
17. Chen, J.Y., et al., & Gronemeyer, H. (1996). Two distinct actions of retinoid-receptor ligands. Nature 382, 819-822.
18. Resche-Rigon, M. & Gronemeyer, H. (1998). Therapeutic potential of selective modulators of nuclear receptor action. Curr. Opin. Chem. Biol. 2, 501-507.
19. Chen, J.Y. et al., & Gronemeyer, H. (1995). RAR-specific agonist/antagonist which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J. 14, 1187-1197.
20. Fanjul, A., et al., & Pfahl, M. (1994). A new class of retinoids with selective inhibition of AP1 inhibits proliferation. Nature 372, 107-111.
21. Nagpal, S., Athanikar, J. & Chandraratna, R.A. (1995). Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha. J. Biol. Chem. 270, 923-927.
22. Ostrowski, J., Roalsvig, T., Hammer, L., Starret, J. Jr., KuLong, J. & Reczek, P. (1998). Serine 232 and methionine 272 define the ligand binding pocket in retinoic acid receptor subtypes. J. Biol. Chem. 273, 3490-3495.
23. Roy, B., Taneja, R. & Chambon, P. (1996). Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta- or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand. Mol. Cell. Biol. 15, 6481-6487.
24. Taneja, R., et al., & Chambon, P. (1996). Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RAR beta 2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts. Proc. Natl Acad. Sci. USA 93, 6197-6202.
25. Vivat, V., et al., & Chambon, P. (1997). A mutation mimics the ligand-induced transconformation of the retinoid X receptor. EMBO J. 16, 5697-5709.
26. Hörlein, A.J., et al., & Rosenfeld, M.G. (1995). Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377, 397-403.
27. Chen, J.D. & Evans, R.M. (1995). A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377, 454-457.
28. Kagechika, H., Kawachi, E., Hashimoto, Y., & Shudo, K. (1986). Differentiation inducers of human promyelocytic leukemia cells HL60. Phenylcarbamoylbenzoic acid and polyene amides. Chem. Pharm. Bull. 34, 2275-2278.
29. Klaholz, B.P., et al., & Moras, D. (1998). Conformational adaptation of ligands to the human nuclear receptor RARγ. Nat. Struct. Biol. 5, 199-202.
30. Hong, W.K. & Sporn, M.B. (1997) Recent advances in chemoprevention of cancer. Science 278, 1073-1077.
31. Ekena, K., Katzenellenbogen, J.A., & Katzenellenbogen, B.S. Determinants of ligand specificity of estrogen receptor-alpha: Estrogen versus androgen discrimination. (1998). J. Biol. Chem. 273, 693-699.
32. Peet, D.J., Doyle, D.F., Corey, D.R., & Mangelsdorf, D.J. (1997). Engineering novel specificities for ligand-activated transcription in the nuclear hormone receptor RXR. Chem. Biol. 5, 13-21.
33. Heery, D.M., Zacharewski, T., Pierrat, B., Gronemeyer, H., Chambon, P., & Losson, R. (1993). Efficient transactivation by retinoic acid receptors in yeast requires retinoid X receptors. Proc. Natl Acad. Sci. USA 90, 4281-4285.
34. Bocquel, M.T., Kumar, V., Stricker, C., Chambon, P. & Gronemeyer, H. (1989). The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor- and cell-specific. Nucleic Acids Res. 17, 2581-2595.
35. Nagpal, S., Saunders, M., Kastner, P., Durand, B., Nakshatri, H. & Chambon, P. (1992). Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 70, 1007-1019.
36. Mader, S., Chen, JY., Chen, Z., White, J., Chambon, P., & Gronemeyer, H. (1993). The patterns of binding of RAR, RXR and TR homo- and heterodimers to direct repeats are dictated by the binding specificities of the DNA binding domains. EMBO J. 12, 5029-5041.
37. Mader, S., Leroy, P., Chen, JY., & Chambon, P. (1993). Multiple parameters control the selectivity of nuclear receptors for their response elements. J. Biol. Chem. 268, 591-600.
38. vom Baur, E., et al., & Losson, R. (1996). Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TlF1. EMBO J. 15, 110-124.
39. Chen, Y. & Presof W.H. (1973). Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (lC50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
40. Jones, T. A., Zou, J. Y., Cowan, S. W. & Kjeldgaard, M. (1991). Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystalllogr. A 47, 110-119.
41. Kleywegt, GJ & Jones, TA. (1994). Detection, delineation, measurement and display of cavities in macromolecular structures. Acta Crystallogr. D 50, 178-185.